Topical tacrolimus treatment of atopic eyelid disease

American Journal of Ophthalmology

Volumn 135, Issue 3, 2003, Pages 297-302

  Rikkers, Sarah M ^a   Holland, Gary N ^a   Drayton, Gail E ^b   Michel, Franz K ^a   Torres, Mark F ^a   Takahashi, Stefani ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; TACROLIMUS;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG USE; ECZEMA; ERYTHEMA; EYELID DISEASE; HERPES SIMPLEX; HUMAN; INFLAMMATION; KERATOCONJUNCTIVITIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; EYELID DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS;

EID: 0037373677     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01982-7     Document Type: Article

References (12)

1. Bielory L. Allergic and immunologic disorders of the eye. Part II ocular allergy . J Allergy Clin Immunol. 106:2000;1019-1032.
2. Liesegang T.J. Atopic keratoconjunctivitis. Pepose J.S., Holland G.N., Wilhelmus K.R. Ocular infection and immunity. 1996;376-390 Mosby-Year Book, St. Louis.
3. Ruzicka T., Assmann T., Homey B. Tacrolimus the drug for the turn of the millennium? Arch Dermatol. 135:1999;574-580.
4. Ruzicka T., Bieber T., Schopf E., et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 337:1997;816-821.
5. Hanifin J.M., Ling M.R., Langley R., et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients part I, efficacy . J Am Acad Dermatol. 44:2001;S28-S38.
6. Soter N.A., Fleischer A.B. Jr, Webster G.F., et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients part II, safety . J Am Acad Dermatol. 44:2001;S39-S46.
7. Mayer K., Reinhard T., Reis A., Bohringer D., Sundmacher R. 0,1% FK 506-Salbe-Eine neue therapeutische Option bei der atopischen Blepharitis. Klinische Studie an 14 Patienten. Klin Monatsbl Augenheilkd. 218:2001;733-736.
8. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derma Venereol. 92:(Suppl):1980;44-47.
9. Wollenberg A., Sharma S., von Bubnoff D., et al. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. [Comment in: J Allergy Clin Immunol 2001;107:445-448.] J Allergy Clin Immunol. 107:2001;519-525.
10. Reitamo S., Rissanen J., Remitz A., et al. Tacrolimus ointment does not affect collagen synthesis results of a single-center randomized trial . J Invest Dermatol. 111:1998;396-398.
11. Reitamo S., Van Leent E.J., Ho V., et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 109:2002;539-546.
12. Reitamo S., Rustin M., Ruzicka T., et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 109:2002;547-555.